Yen, Cho-Li <br/><br/>
Ribavirin monotherapy increases sustained response rate in relapsers of end treatment virologic responders.  [electronic resource] 

 -  World journal of gastroenterology  Mar 2005 
 - 1663-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1007-9327 
<br/><br/><label>Standard No.: </label>10.3748/wjg.v11.i11.1663  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Cost Savings<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Ribavirin--administration & dosage<br/>Treatment Outcome<br/>Viral Load